Literature DB >> 16687040

Perforation of the esophagus caused by the insertion of an intragastric balloon for the treatment of obesity.

H W Nijhof1, P Steenvoorde, R A E M Tollenaar.   

Abstract

Obesity is an enduring chronic disease, with multifactorial etiology. Many procedures and solutions have been proposed in the last 25 years. If patients do not meet the criteria for bariatric surgery, intragastric balloons may be used to achieve weight reduction. Contraindications to balloon therapy are a large hiatal hernia, severe esophagitis, peptic ulceration and previous gastric surgery. Although intragastric balloons are advocated as safe devices, major complications such as intestinal obstruction, gastric perforation and gastric ulceration have been described. We report a case of esophageal rupture due to insertion of an intragastric balloon for the treatment of morbid obesity, for which no contraindication existed. When abnormal pain or discomfort arises, or esophageal damage is noted after insertion of an intragastric balloon, patients must be closely monitored to diagnose a possible esophageal rupture early and thereby prevent severe complications.

Entities:  

Mesh:

Year:  2006        PMID: 16687040     DOI: 10.1381/096089206776944887

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  13 in total

1.  Esophageal perforation after gastric balloon extraction.

Authors:  Dan Ruiz; Kelly Vranas; Davida A Robinson; Liberato Salvatore; James W Turner; Talat Addasi
Journal:  Obes Surg       Date:  2008-08-08       Impact factor: 4.129

2.  Thoracic Complications of Bariatric Surgeries: Overlooked Entities.

Authors:  Yasser Aljehani; Abdullah Saleh AlQattan; Feras Ahmed Alkuwaiti; Farah Alsaif; Ibrahim Aldossari; Hatem Elbawab
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

3.  Mechanical ileus induces surgical intervention due to gastric balloon: a case report and review of the literature.

Authors:  Marty Zdichavsky; Stefan Beckert; Markus Kueper; Michael Kramer; Alfred Königsrainer
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

4.  Medical management of iatrogenic esophageal perforations.

Authors:  Ryan D Madanick
Journal:  Curr Treat Options Gastroenterol       Date:  2008-02

5.  Intragastric balloon fundal or antral position affects weight loss and tolerability.

Authors:  Theodossis S Papavramidis; Vasilis Grosomanidis; Pyrros Papakostas; Sofia Penna; Katerina Kotzampassi
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

6.  Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass.

Authors:  Maria Dolores Frutos; Maria Dolores Morales; Juan Luján; Quiteria Hernández; Graciela Valero; Pascual Parrilla
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

7.  Gastric perforation during removal of an intragastric balloon.

Authors:  Pablo del Pozo; Benito Flores; Ramon Lirón; Bruno Andrés; Juan Gervasio Martin-Lorenzo; Silvia Chacón; Pilar Esteban; Jose Luis Aguayo-Albasini
Journal:  Obes Surg       Date:  2009-05-30       Impact factor: 4.129

8.  Gastric perforation and death after the insertion of an intragastric balloon.

Authors:  Ioannis Koutelidakis; Dimitrios Dragoumis; Basilios Papaziogas; Aristidis Patsas; Alexandros Katsougianopoulos; Stefanos Atmatzidis; Konstantinos Atmatzidis
Journal:  Obes Surg       Date:  2008-10-02       Impact factor: 4.129

9.  Gastric necrosis: a possible complication of the use of the intragastric balloon in a patient previously submitted to nissen fundoplication.

Authors:  José Ignacio Rodríguez-Hermosa; Josep Roig-García; Jordi Gironès-Vilà; Bartomeu Ruiz-Feliú; Patricia Ortiz-Ballujera; María Rosa Ortiz-Durán; Antoni Codina-Cazador
Journal:  Obes Surg       Date:  2009-06-09       Impact factor: 4.129

10.  Bio-enteric intragastric balloon in obese patients: a retrospective analysis of King Faisal Specialist Hospital experience.

Authors:  Khalid Al Kahtani; Mohammed Qaseem Khan; Ahmed Helmy; Hamad Al Ashgar; Mohammed Rezeig; Mohammed Al Quaiz; Ingvar Kagevi; Mohamed Al Sofayan; Mohammed Al Fadda
Journal:  Obes Surg       Date:  2008-08-28       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.